Back to results
US 2026/0077050 A1Published application
Protac degraders of sars-cov-2 main protease
OwnerShiqing Xu, Wenshe Liu +3inventors
InventorsShiqing Xu, Wenshe Liu, Benjamin Neuman, Yugendar R. Alugubelli, Kaustav Khatua
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to certain molecules, pharmaceutical compositions containing them, and methods of using them to treat viral infections.
Claims20
A conjugate having a formula Q-L-P, wherein
- Q is a radical of a ubiquitin ligase ligand;
- L is a divalent linker;
- and
- P is a radical of a SARS-CoV-2 protease ligand.
1 more element
Dependencies are inferred from the claim text.